Authors

Empowering Breast Surgeons: A Call for Collective Action

As survival rates continue to rise for patients with breast cancer, innovations are still needed to advance surgical care for these patients.

Montefiore Einstein Comprehensive Cancer Center Upholds Top Honor for Cancer Care

MECCC Earns Three-Year Accreditation from the Commission on Cancer of the American College of Surgeons – Again!

Overall Survival After Surgery for Spinal Metastases Has Improved Over the Past Two Decades

Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine.

A Breakthrough for the “Lab Brat”

Building on research his father conducted decades earlier, Robert Orlowski, MD, PhD, redefined myeloma treatment.

Ongoing Research on MRD Detection May Shift Outcomes for Posttransplant AML

The prediction of relapse following treatment with allogeneic stem cell transplant in patients with acute myeloid leukemia in first complete remission remains an unmet need due to limitations attributed to measurable residual disease detection methods.

Q&A

Breast Nerve Preservation and Grafting: How Surgeons Can Help Mitigate Sensation Loss

More surgeons are having in-depth conversations with their patients with breast cancer and prophylactic patients about the fact that nerves will have to be cut during their mastectomy, how that will impact sensation and quality of life, and how surgeon collaboration and breast neurotization can help restore sensation.

Preparing and Delivering a Virtual Learning Session

Strategies are important to optimize learning in the virtual environment including speaker preparation, creating a virtual learning climate, and encouraging and enhancing interaction.

Trainees Deserve Better Feedback

Feedback plays a key role in medical edu-cation and faculty development as it allows everyone to evaluate their performance and improve their intrapersonal skills.

Ongoing Research on MRD Detection May Shift Outcomes for Posttransplant AML

The prediction of relapse following treatment with allogeneic stem cell transplant in patients with acute myeloid leukemia in first complete remission remains an unmet need due to limitations attributed to measurable residual disease detection methods.

Ipilimumab Plus Nivolumab With Chemoradiotherapy Leads to Bladder Preservation in Urothelial Carcinoma of the Bladder

Induction ipilimumab plus nivolumab followed by consolidative chemoradiotherapy led to bladder preservation in stage 2/3 urothelial carcinoma of the bladder.

The US Oncology Network Expands its Tennessee Service Area as Tennessee Cancer Specialists Joins The Network

Tennessee Cancer Specialists, the third largest oncology practice in the state, strengthens its ability to deliver cutting-edge advanced care by joining The Network.

Seeing Medicine Through the Eye of an Artist

For many people who go into research, there’s a moment somewhere along the way that is immediately addictive and makes you want to experience that over and over again.

Future Considerations for Treatment Sequencing in B-ALL

Experts share their final thoughts on the unmet needs and future perspectives of chimeric antigen receptor (CAR) T-cell therapy for hematologic malignancies, emphasizing areas for improvement and potential advancements in treatment.

Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant

Northwestern Medicine pioneered a total artificial lung system, enabling successful double-lung transplants.

Prominent Scientist Julio Aguirre-Ghiso, Ph.D., To Lead New Cancer Dormancy and Tumor Microenvironment Institute at Albert Einstein Cancer Center

Leading cancer biologist Julio Aguirre-Ghiso, PhD, has been named founding director of the Cancer Dormancy and Tumor Microenvironment Institute, director of the Gruss-Lipper Biophotonics Center, and co-leader of the AECC Tumor Microenvironment and Metastasis Program.